| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Pediatrics, Pediatric Gastroenterology & Nutrition, Erasmus Medical Center, and Sophia Children's Hospital, Rotterdam, The Netherlands
To gain insight into mucin 2 (Muc2) synthesis and secretion during dextran sulfate sodium (DSS)-induced colitis, rats were treated with DSS for 7 days. Colonic segments were excised on days 0 (control), 2 (onset of disease), 7 (active disease), and 14 (regenerative phase) for histological evaluation. Explants were metabolically labeled with 35S-labeled amino acids or [35S]sulfate followed by chase incubation. Homogenates were analyzed by SDS-PAGE and 35S-labeled Muc2 was quantified. Also, total Muc2 protein and mRNA were quantified. DSS-induced crypt loss, ulcerations, and concomitant goblet cell loss were most pronounced in the distal colon. Muc2 precursor synthesis increased progressively in the proximal colon but was unaltered in the distal colon during onset and active disease. During the regenerative phase, Muc2 precursor synthesis levels normalized in the proximal colon but increased in the distal colon. Total Muc2 levels paralleled the changes seen in Muc2 precursor synthesis levels. During each disease phase, total Muc2 secretion was unaltered in the proximal and distal colon. [35S]sulfate incorporation into Muc2 only decreased in the proximal colon during active disease and the regenerative phase, whereas secretion of [35S]sulfate-labeled Muc2 increased. During the regenerative phase, Muc2 mRNA levels were downregulated in both colonic segments. In conclusion, DSS-induced loss of goblet cells was accompanied by an increase or maintenance of Muc2 precursor synthesis, total Muc2 levels, and Muc2 secretion. In the proximal colon, Muc2 became undersulfated, whereas sulfated Muc2 was preferentially secreted. Collectively, these data suggest specific adaptations of the mucus layer to maintain the protective capacities during DSS-induced colitis.
mucin labeling; Muc2 sulfation; goblet cells; proximal and distal colon
This article has been cited by other articles:
|
|
 |
|
  G. An, B. Wei, B. Xia, J. M. McDaniel, T. Ju, R. D. Cummings, J. Braun, and L. Xia Increased susceptibility to colitis and colorectal tumors in mice lacking core 3 derived O-glycans J. Exp. Med., June 11, 2007; 204(6): 1417 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Clark, S. M. Doelle, M. D. Halpern, T. A. Saunders, H. Holubec, K. Dvorak, S. A. Boitano, and B. Dvorak Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G938 - G949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Daddaoua, V. Puerta, P. Requena, A. Martinez-Ferez, E. Guadix, F. Sanchez de Medina, A. Zarzuelo, M. D. Suarez, J. J. Boza, and O. Martinez-Augustin Goat Milk Oligosaccharides Are Anti-Inflammatory in Rats with Hapten-Induced Colitis J. Nutr., March 1, 2006; 136(3): 672 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Boshuizen, J. H. J. Reimerink, A. M. Korteland-van Male, V. J. J. van Ham, M. P. G. Koopmans, H. A. Buller, J. Dekker, and A. W. C. Einerhand Changes in Small Intestinal Homeostasis, Morphology, and Gene Expression during Rotavirus Infection of Infant Mice J. Virol., December 15, 2003; 77(24): 13005 - 13016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. B. Renes, M. Verburg, D. J. P. M. Van Nispen, H. A. Buller, J. Dekker, and A. W. C. Einerhand Distinct epithelial responses in experimental colitis: implications for ion uptake and mucosal protection Am J Physiol Gastrointest Liver Physiol, July 1, 2002; 283(1): G169 - G179. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
